In The News Posted March 6, 2019 Share Posted March 6, 2019 SOUTH SAN FRANCISCO, Calif., March 6, 2019 /PRNewswire/ -- ORIC Pharmaceuticals, a privately held, clinical-stage oncology company focused on the discovery and development of novel therapies against treatment-resistant cancers, announced that Jacob Chacko, MD, Chief Executive Officer,... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.